2419P Clinical consequences of therapy related clonal hematopoiesis in patients treated with PSMA- targeted radionuclide therapy
Pinkal Desai(NewYork–Presbyterian Hospital), S.T. Tagawa(Cornell University), Áurea Molina(Cornell University), Joelle Y.H. Chua(Cornell University), Kathryn Gorski(Cornell University), Chantal Chanel‐Vos(Albert Einstein College of Medicine), Michael Sigouros(Cornell University), Nuria Mencia-Trinchant(NewYork–Presbyterian Hospital), Andrea Sboner(Cornell University), C.N. Sternberg(Cornell University), Mónica L. Guzmán(NewYork–Presbyterian Hospital), D.M. Nanus(Cornell University), Olivier Elemento(Cornell University), Neil H. Bander(Convergent Science (United States)), David Wilkes(Cornell University), Zheng Li(ETH Zurich), Shengtao Yuan(China Pharmaceutical University), Jyothi Manohar(Cornell University), Rohit Joshi(Sorbonne Université), Gail J. Roboz(Cornell University)
Cited by 1
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
|Cell Research|2014|1.6k